Kazmi Syed 4
4 · LIGAND PHARMACEUTICALS INC · Filed Mar 1, 2011
Insider Transaction Report
Form 4
Kazmi Syed
VP, Bus. Dev. & Strategic Plan
Transactions
- Sale
Common Stock
2011-02-28$10.70/sh−100$1,070→ 15,296 total - Sale
Common Stock
2011-02-28$10.68/sh−866$9,249→ 14,230 total - Sale
Common Stock
2011-02-28$10.69/sh−100$1,069→ 15,096 total - Sale
Common Stock
2011-02-28$10.71/sh−100$1,071→ 15,196 total
Footnotes (1)
- [F1]Shares sold to cover taxes on the vesting of restricted stock.